Bristol immunotherapy gets six month U.S. FDA review for melanoma

[riky]

Bristol immunotherapy gets six month U.S. FDA review for melanoma

(Reuters) - The U.S. Food and Drug Administration has granted a six-month, priority review to Bristol-Myers Squibb Co's application for immuno-oncology drug Opdivo as a treatment for previously treated melanoma, the company said on Friday. The FDA decision is due by March 30, 2015. Bristol said European regulators have also agreed to an accelerated review of the drug as a treatment for advanced melanoma. ...

Source: You are not allowed to view links. Register or Login